Recently we have created a mouse model of cystic fibrosis (CF) by insertional gene targeting to exon 10. In common with CF subjects, this model displays a low incidence of meconium ileus. This contrasts strikingly with the very high level of fatal intestinal obstruction in the three other CF mouse models so far described. We investigate here the molecular basis of this difference in phenotype. We show that the partial duplication consequent upon insertional gene targeting allows exon skipping and aberrant splicing to produce normal Cftr mRNA, but at levels greatly reduced compared with wild-type mice. Furthermore, instead of the predicted mutant Cftr transcript, a novel mRNA is produced that utilizes cryptic splice sites in the disrupting plasmid sequence. However, we have previously shown that these mice display the ion transport defect characteristic of CF, and mutant animals can be distinguished from their normal littermates on this basis. Consistent with this, residual CFTR function has recently been observed for several "mild" mutations in CF individuals who display pancreatic sufficiency but still develop lung disease. We conclude that (i) residual wild-type mRNA in the exon 10 insertional mutant mouse ameliorates the severity of the intestinal phenotype observed in the absolute "null" CF mice, (ii) the presence of low-level residual wild-type Cftr mRNA does not correct the CF ion transport defect, and (iii) the long-term survival of this insertional mutant mouse provides the opportunity to address the factors important in development of lung disease.
Introduction
The identification and characterization of the cystic fibrosis transmembrane conductance regulator (CFTR) gene
Correspondence to: J.R. Dorin (Riordan et al. 1989 ) confirmed the long-standing hypothesis that defective cAMP-mediated chloride secretion was the primary biochemical defect in cystic fibrosis (CF) epithelium (Welsh 1990 ). Isolation of the mouse gene made possible experiments designed to model the disease in the mouse by gene targeting in embryonal stem cells. The amino acid sequence of the murine CFTR protein is very similar to that in human, particularly in the two nucleotide-binding folds (Tara et al. 1991; Yorifuji et al. 1991) . In addition, it had previously been demonstrated that the ion transport properties of wild-type mice are similar to those of normal human subjects ).
Thus, Cftr gene disruption in the mouse was predicted to result in a comparable primary defect to that seen in CF patients. To date four groups have described the generation of mouse models for CF by gene targeting. All of the mice can be distinguished from their normal littermates on the basis of electrophysiological assays consistent with defective chloride ion transport Ratcliff et al. 1993; Dorin et al. 1992; O'Neal et al. 1993) . For the purposes of this report we discriminate between these mice by reference to the laboratory of origin, as shown in Table  1 . The transgenic animals created by three of the groups involved disruptions of exon 10 in the murine Cftr gene [Snouwaert et al. 1992 (UNC); Dorin et al. 1992 (HGU); Colledge et al. 1992 (Cam) ] and the fourth group targeted exon 3 [O'Neal et al. 1993 (Bay) ]. The targeting strategies employed by two of the groups targeting exon 10 (CftrmlgNC; Cftr mlcam) were very similar, based on the positive-negative selection (PNS) "replacement" gene targeting scheme (Capecchi 1989) . Correct gene targeting occurs through a double reciprocal exchange between homologous gene and vector sequences, and, as a consequence, the region of the endogenous gene that lies between the crossovers is replaced. Thus there can be no reversion to wild type, and the mutations are absolute "nulls". Dorin et al. (1992) and O'Neal et al. (1993) both (1993) and this publication a Nomenclature of the mice generated by Snouwaert et al. (1992) at University of North Carolina (cfir ~"m~sc) is used by The Jackson Laboratory (Bar Harbor). The nomenclature of mice generated by Colledge et ah(1992) at the University of Cambridge (cftr mlcam) and by O'Neal et al. (1993) at Baylor College of Medicine (cfi/'~IBay) has been used previously by them (Ratcliff et al. 1993; O'Neal et al. 1993 respectively) . The nomenclature of the mouse generated by Dorin et al. (1992) Dorin et al. (1992) differ significantly from those described by the other three groups. The majority of the exon 10 replacement and exon 3 insertional mutant mice die from intestinal perforation and peritonitis resulting from gut blockage present perinatally or at weaning (Table 1) . This contrasts markedly from the exon 10 insertional mutant mice where, in common with CF individuals (Mearns 1992) , the majority of homozygous mutant mice (cf/cj) display mild intestinal disease with only 10% dying from gut blockage (similar to meconium ileus) at birth or post weaning. The cftr mm6U mice can be clearly identified by their in vivo electrophysiological properties, which reflect the characteristic bioelectric features of CF (Dorin et al. 1992; Alton et al. submitted) .
There are several possible explanations why the cftr mmaU mutant mice display long-term survival, whereas the other mutant mice do not. CF subjects with identical CFTR mutations display a wide spectrum of disease severity, and this heterogeneity can be attributed to either environmental or other genetic components, and is most likely owing to a combination of both. The exon 10 insertional mice were bred into an outbred strain of mice (MF1), whereas the other CF mice were initially crossed with other inbred mouse strains bred onto inbred mice strains. (Ratcliff et al. 1993) 
Materials and methods

Histology
Tissues were fixed in 10% neutral buffered formalin and then dehydrated through increasing alcohol series, cleared in xylene, and infiltrated with paraffin wax. Paraffin blocks were sectioned and slides stained with hematoxylin and eosin.
Quantitation of wild-type Cftr in cf/cf mice
Poly A mRNA was extracted from snap frozen tissue, converted to cDNA, and subjected to amplification by PCR with Taq polymerase as previously described (Alton et al. 1993 ). The PCR reactions were carried out at 55~ annealing for 45 s, 72~ extension for 1 rain 30 s, and 92~ denaturation for 25 s. For control of the amount of mRNA present in the reaction, the same sample was amplified with both oligonucleotides specific for mouse PCNA (Yamaguchi et al. t991; 5'GGT TGG TAG TTG TCG CTG TA sense and 5'CAG GCT CAT TCA TCT CTA TGG antisense). This produces a product of 720 bp encompassing exons 1-4 and hybridizes to the specific internal oligonucleotide PCNA 1 (5'CTG GTA ATG AAG ACA TC) at 45~ The wild-type mouse Cftr gene was amplified with an exon 9 primer (5'AGC AAT GGT GAC AGA AAA CAT TCC) and an exon 1 t primer (5'CTT GCT AAA GAA ATC CTT GCA GGC) and hybridized to an exon 10-specific primer (5'GGG AGA ACT CGA AGC TTC) at 50~ Hybridization of specific primers was quantitated by analysis with a Molecular Dynamics PhosphorImager.
Cloning of mutant Cftr mRNA
The 644-bp mutant fragment from cftr~m~U-derived mRNA was amplified with oligonucleotides phosphorylated with polynucleotide kinase (BCL) and isolated from an agarose gel. The agarose slice was treated with [3-agarase and T4 DNA Polymerasc (BCL) and Turbo cloned by use of the Cre (NEN) protein into a lox modified Bluescribe vector (Boyd 1993) . Plating the ligation out onto X-gal revealed that white colonies outnumbered blue colonies by 10 to 1, and 90% of the white colonies contained the correct insert. Both strands of several clones were sequenced with Sequenase dideoxy-sequencing.
Results
Survival of the exon 10 cftr ~IHcU mice Table 1 shows a comparison of the survival rates of the CF mutant mice described by the four groups. Of the offspring born over a 4-month period to heterozygotes carrying the Cftl "rnlHGU mutation, there were approximately 60 perinatal deaths. Of these, 24 were cf/cf 27 cf/+, and 9
were + / + . These numbers deviate significantly with Z 2 (p = 0.15 with two degrees of freedom) from the expected Mendelian ratio of 1:2:1 if perinatal death was due to nongenetic factors. Thus, if we assume that the number of + / + animals reflects the expected number of cf/cf perinatal deaths by chance, then there is an excess of -1 5 cf/cfanimals. Of the 24 cf/cfperinatal deaths, only 12 were available for macroscopic and histological examination. Of these, six displayed abdominal distension resulting from gross intestinal obstruction, which was more pronounced distal to the caecum. It is, therefore, likely that a similar fraction of the remaining 12 animals that were too damaged to be examined in detail would also display intestinal blockage as the cause of death. Thus we estimate an incidence of --5% fatal meconium ileus for the cftr ~m~ transgenic mice on the MF1 background. Figure 1 shows histological examination of the colon of a newborn cftr mlHcU mouse and demonstrates the accumulation of meconium that has resulted in the flattening of the normal architecture of the intestine. This is very similar to the gut blockage described for the cftr mlUNc, cftr mmay, and cftr "1cam mice, but which affects 40-80% of these newborn animals. In addition, a further nine cftr " m c u animals ( -5 % ) died or were sacrificed post weaning owing to an apparent gut distension making movement difficult. These animals on macroscopic examination all displayed gross blockage and distension of the large intestine with a large accumulation of putty-like material consistent with distal intestinal obstruction syndrome described in 20% of CF patients outwith the neonatal period (Boat et al. 1989 ). Histological examination revealed a huge accumulation of mucin and deformation of the epithelial lining of the intestine of these cft/'lHaU animals (data not shown). We have previously reported (Dorin et al. 1992 ) the abnormal mucin accumulation and resultant epithelial cell distension which occurs in --75% of the Cftr ~mcU mutant animals that display no overt external abnormality.
Transcripts derived from exon 10 Cftr insertional mutation
The structure of the targeted insertional mutation introduced into exon 10 of the Cftr gene of the Edinburgh cftr m~Hce mouse (Dorin et al. 1992 ) is shown in Fig. 2a .
Insertion of a truncated exon 10 with stop codons in all reading frames occurs without sequence loss and leaves a displaced intact exon 10 downstream of the inserted vector. As shown in Fig. 2b(i (ii) Wild-type mRNA produced by skipping the disrupted exon 10. This includes exons 9, 10, and 11 adjacent to each other and can be detected with RT-PCR from exons 9-11. PCR amplimers 9A and 11B and the intact exon 10-specific internal oligouucleotide are indicated. Exons 9-11 produce a 438-bp CJ~r gene fragment. (iii) Mutant mRNA including a plasmid-derived exon (see Fig. 4a and 4b). In order to determine whether the cf/cf mice synthesize wild-type Cftr m R N A (Fig. 2bii) , we used RT-PCR from exon 9 to exon 11. Only if wild-type message was produced would a signal of the correct 438-bp size be observed. An internal oligonucleotide specific for the endogenous wildtype exon 10 (but not present in the vector-derived disrupted exon 10) was used as a probe to verify the identity of any D N A fragment observed. An initial 30-cycle RT-PCR amplification of poly A m R N A from testes revealed wild-type m R N A in all three genotypes of mice, although this was severely reduced in homozygous cf/cfmice (data not shown). To quantitate more accurately the amount of wild-type m R N A by RT-PCR, relative levels were assessed during the exponential stage of amplification. We devised a duplex RT-PCR using the Cftr exon 9 and 11 primers together with primers specific for a control gene PCNA (proliferating cell nuclear antigen). It was thus possible to correct for the amount of m R N A in each sample by comparison with the level of PCNA amplification during the exponential phase. Figure 3a shows representative Southern blots of RT-PCR reactions hybridized with either a PCNA-specific internal o l i g o n u c l e o t i d e or the Cftr exon 10 internal oligonucleotide. Approximately equivalent amounts of amplification products for PCNA were aligned, and the corresponding signal obtained when rehybridized with the Cftr internal oligonucleotide is also shown. However, quantitation of the signal by PhosphorImager showed that, although the relationship between cycles is exponential, it is not 100% efficient. of the normal level in wild-type mice. This value varies between mice with 2N = 2B > 2J > 2A in the lung. 2N synthesizes approximately 10% of the normal level of wildtype Cftr in the lung, while 2A synthesizes approximately 2% of the normal level. In the colon, the values obtained were different in that the relative levels of m R N A were 2A < 2J < 2B = 2N. The level of wild-type m R N A in 2B and 2N was barely detectable, and the level of 2J was approximately 8%, but the level of 2A Cftr m R N A was approximately 20% of that observed in wild-type mice. These results and ranking order in both lung and colon were con- The corresponding signal observed with the Cftr oligonucleotide was also aligned as shown. Fig. 3b was carried out on lung and colon samples. In animals carrying the mutant gene, both an upper 644-bp fragment and lower 438-bp exon 10 hybridizing fragment were observed, but in wildtype animals only the predicted 438-bp fragment was seen. m indicates the mutant specific band and wt the wild-type band. Fig. 4b . Cftr mutant transcript, The mutant specific exon 9-11 RT-PCR fragment was cloned and sequenced and the sequence is shown. Exon 9 from the Cftr gene is spliced onto a 206-bp fragment of pMCneopolyA plasmid sequence and then back to an intact exon 10. Thus, the disrupted exon 10 is not used. The consensus splice sites for eukaryotic genes are shown above the plasmid exon splice sites with the exon flanking bases shown in bold. Exonic sequence is shown in u p p e r case and plasmid intron shown in small case letters. Translation of this plasmid exon in frame from exon 9 terminates nine amino acids into the novel sequence. There are stop codons in all three reading frames in this mutant insert.
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sistent over different experiments with fresh aliquots of mRNA from the same animal.
Characterization of a mutant-specific mRNA
Although we could not detect the predicted mutant mRNA, Fig. 4a demonstrates that, using the exon 9-11 RT-PCR, we have consistently detected a novel PCR fragment of approximately 644 bp in size, which also hybridizes to the intact exon 10-specific primer and was present in both heterozygous cf/+ and homozygous cf/cfmutant but not wildtype + / + animals. To further characterize this mutant mRNA, we cloned and sequenced the PCR fragment. The sequence is shown in Fig. 4b and demonstrates that a 206-bp fragment from the targeting plasmid pMCneopolA (Stratagene) is spliced between Cftr exons 9 and 10 ( Fig.   2b iii). The splice site utilized at the 3' end of the plasmid exon is AGA GTAAGT, and the splice at the 5' end of the exon is CATAG T with the exon flanking bases (highlighted) not deviating from the GT-AG base rule for splice site selection. The plasmid sequence within this mRNA contains stop codons in all three reading frames and would, therefore, translate into a nonfunctional protein truncated after exon 9. The stability of such a mRNA might be expected to be severely reduced. In the lungs of four cf/cfanimals, the mutant mRNA was present at a level approximately twofold higher than that of wild-type Cftr mRNA (Fig. 4a) . In the colon, the mutant and normal wild-type mRNA were at roughly equivalent levels in all four animals.
Discussion
The mutant mRNAs derived from the cftr m/HGv insertional mice were not as predicted. The expected mutant mRNA could not be detected, and a novel mRNA was present (Fig. 2b iii) . The sequence of this mRNA contains an in-frame stop at a position less than half way into the message. This might be expected to destabilize the mRNA (Daar and Maquat 1988) . Mutant mRNAs that contain premature stop codons are often present at a reduced level in the cytoplasm (McIntosh et al. 1993) . Indeed, CF patients have been described who carry nonsense mutations and display a severe deficiency of the CFTR mRNA derived from the allele with the premature stop codon (Hamosh et al. 1991) . Two models have been put forward to explain this phenomenon (Urlaub et al. 1989) . The "translational translocation model" curtails entry of the mRNA into the cytoplasm by halting the normal process of the translational machinery pulling the mRNA through the nuclear pore. The "nuclear scanning model" screens pre-mRNAs in the nucleus for nonsense mutations and in this case might promote skipping of the disrupted exon 10 and allow accumulation of wild-type Cftr mRNA in the cytoplasm. Lim et al, (1992) report nucleolytic cleavage of premature termination codons containing mRNAs by a cytoplasmic process with no effect on nuclear mRNA metabolism. These models may not be mutually exclusive and would both result in a reduction of the amount of mutant mRNA found in the cytoplasm compared with the nucleus. This may explain the absence of the predicted mRNA (Fig. 2b i) in poly A mRNA. The predicted protein sequence of the novel mutant mRNA (Fig. 4b ) would terminate after exon 9 within the first nucleotide-binding fold of the CFTR protein and consequently would be nonfunctional. The difference in severity of intestinal phenotype between the Edinburgh cftr 'nmGU mutant mice and the CF mice described by three other groups is most likely the result of low-level residual expression from the exon 10 insertional mutation. The replacement mice created by Snouwaert and coworkers (1992) must be absolute null mutations as by definition they lack an intact exon 10. In addition, they demonstrate experimentally the absence of normal mRNA in -/ -mice. The intrinsically low level of wild-type Cftr mRNA in the lung of normal mice makes quantitation of the levels in mutant animals difficult. However, the sensitive RT-PCR assay used on the cf/cfmice described here produced comparable estimates on repeat processing that was typically less than 10% of wild-type levels in the lung. This wild-type mRNA results from aberrant splicing and exon skipping consequent upon the exon 10 insertional event. It is unlikely that the disrupted exon 10 would be skipped owing to mechanisms for exon definition (Robberson et al. 1990 ) as suggested by O'Neal and associates (1993) because it includes in-frame stop codons and thus would act as a terminal 3' exon. These exons contain poly(A) addition sites and are frequently extremely long (Robberson et al. 1990 ). Interestingly, alternative splicing around adjacent regions of the CFTR gene in mouse (Delaney et al. 1993 ) and human (Chu et al. 1991) has previously been demonstrated. The novel mutant mRNA described here demonstrates that the disrupted exon 10 5' splice sequence can be efficiently excluded from splice selection. A precedent for a leaky insertional mutation generated by gene targeting has recently been described by Moens and colleagues (1992) for the N-Myc gene. These transgenic mice die perinatally as opposed to N-myc replacement mice, which die during embryogenesis. The insertional N-myc mice express reduced levels of wild-type mRNA, which varies from tissue to tissue. Brain expresses 50% of wild-type levels, kidney 32%, and lung 24% of wild-type levels. The lung alone shows an abnormality in morphogenesis and thus reveals a novel role for N-myc obscured by the more severe replacement mutant mice. Moens and coworkers (1992) could find no evidence for reversion by vector deletion. The wild-type mRNA expressed from the insertional Cftr "~l/4GU mutation is peculiar to the exon 10 insertion because the exon 3 Cfir ~'l€ insertional mice also have the severe phenotype, and RNase protection studies failed to detect wild-type Cftr production in homozygous mutant mice ( -/ -) . Insertional mutations are not intrinsically "leaky". Hprt insertional gene disruptions have been shown to be absolute "nulls" under stringent biochemical selection (Deng and Capecchi 1992) .
In the intestine CFTR mRNA is expressed at higher levels in both + / + and mutant mice than in their respective airways, and cAMP-mediated chloride secretion is also generally greater in the intestinal tract, in particular in the cecum. The low levels of mRNA found in the exon 10 insertional model appear to be sufficient to result in clearance of meconium in 95% of animals perinatally and 90% of animals overall.
Up to 10% of wild-type Cftr mRNA is present in the lungs of insertional mutant cf/cf mice, yet cAMP-mediated chloride secretion is still markedly reduced. This finding is consistent with the recent analysis of chloride transport in CF patients with various missense mutations. Sheppard and associates (1993) report that the chloride conductance of R347P and R117H mutant constructs in the vaccinia virus T7 hybrid expression system are approximately 30% and 15% of wild-type values respectively. Individuals who are R347P/AF508 or R117H/AF508 compound heterozygotes are therefore predicted to retain approximately 15% or 7.5% of normal CFTR function. However, these individuals are still diagnosed as having CF and still develop severe lung disease although the pancreatic involvement is ameliorated. Indeed, the Cystic Fibrosis Genotype-Phenotype Consortium (1993) recently reported the conclusion that genotype could predict pancreatic status but not the occurrence of common complications or the severity or course of pulmonary disease.
In conclusion, these exon 10 insertional CF mutant mice demonstrate long-term survival consequent on a low level of residual wild-type Cftr mRNA. This level is not sufficient to correct the ion transport defect characteristic of CF in either the respiratory or intestinal tract (Dorin et al. 1992; Alton et al. 1993; Smith et al. submitted) . Thus, they are a useful model for testing novel therapeutic strategies including somatic gene therapy (Alton et al. 1993 ). The major cause of morbidity and mortality in CF is lung disease. However, CF infants display no evidence of lung abnormalities at birth, and it is presumed that environmental factors contribute heavily to the development of the pulmonary complications. The long-term survival of this particular CF mouse model provides the opportunity to address which factors are necessary for development of CF lung disease.
